Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133685) titled 'Evaluation of Serum IL-7 as a Biomarker in Breast Cancer' on Aug. 14.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Breast Cancer
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 140
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07133685
Published by HT Digital Content Services with permission from Health Daily Digest....